Skip to main content

Table 5 Multivariate analysis of independent prognostic factors for DSS and OS in patients with invasive carcinoma of the breast (pooled NEC and IMC-NOS)

From: Invasive neuroendocrine carcinoma of the breast: a population-based study from the surveillance, epidemiology and end results (SEER) database

Group

DSS

 

OS

 

HR (95% CI)

P

HR (95% CI)

P

Age, years (>60 vs ≤60)

1.14 (1.13-1.16)

<0.0001

2.62 (2.60-2.65)

<0.0001

Tumor size, mm (>20 vs ≤20)

1.65 (1.64-1.66)

<0.0001

1.34 (1.33-1.35)

<0.0001

LN (positive vs negative)

1.98 (1.97-2.00)

<0.0001

1.64 (1.63-1.65)

<0.0001

Grade (III vs I, II)

1.26 (1.25-1.27)

<0.0001

1.12 (1.11-1.13)

<0.0001

ER status (positive vs negative)

0.82 (0.81-0.83)

<0.0001

0.90 (0.89-0.91)

<0.0001

PR status (positive vs negative)

0.88 (0.87-0.89)

<0.0001

0.93 (0.92-0.94)

<0.0001

Neuroendocrine (positive vs negative)

1.80 (1.36-2.37)

<0.0001

1.84 (1.50-2.26)

<0.0001

Radiation (yes vs no)

0.90 (0.89-0.91)

<0.0001

0.75 (0.74-0.76)

<0.0001

Surgery (yes vs no)

0.44 (0.43-0.45)

<0.0001

0.45 (0.46-0.47)

<0.0001

  1. DSS, disease-specific survival; OS, overall survival; NEC; neuroendocrine carcinoma; IMC-NOS, invasive mammary carcinoma, not otherwise specified; HR, hazard ratio; CI, confidence interval; LN, lymph node; ER, estrogen receptor; PR, progesterone receptor.